Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Penthienate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 12/20 | 0.49 |
| ▸ | CHRM2 known ✓ | P08172 | 11/20 | 0.49 |
| ▸ | CHRM3 known ✓ | P20309 | 12/20 | 0.49 |
| ▸ | CHRM4 known ✓ | P08173 | 4/20 | 0.49 |
| ▸ | CHRM5 known ✓ | P08912 | 1/20 | 0.49 |
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Penthienate SCHEMBL250881 | 0.81 | CHRM1 (0.67) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| Penthienate SCHEMBL31393386 | 0.80 | CHRM1 (0.68) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| Penthienate SCHEMBL28086303 | 0.76 | CHRM1 (0.62) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| Pentapiperide SCHEMBL25997 | 0.74 | MEN1 (0.51) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| Oxyphenonium SCHEMBL248890 | 0.69 | CHRM2 (0.98) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| Valethamate SCHEMBL249506 | 0.69 | CHRM1 (1.00) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| Oxyphenonium SCHEMBL250614 | 0.68 | CHRM2 (1.00) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| Oxyphenonium SCHEMBL250615 | 0.68 | CHRM2 (1.00) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| SCHEMBL15095409 | 0.68 | CHRM2 (0.62) | CHRM1CHRM2SLC6A3KCNH2CHRM3 | |
| Valethamate SCHEMBL249537 | 0.68 | CHRM1 (0.97) | CHRM1CHRM2SLC6A3KCNH2CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7026360-B1 | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients | INPHARMA S.A. (CH) | 2006-04-11 | — | — | US | disclosed |